Literature DB >> 27149875

The role of prophylactic neck dissection and tumor thickness evaluation for patients with cN0 tongue squamous cell carcinoma.

Nayuta Tsushima1, Tomohiro Sakashita1, Akihiro Homma2, Hiromitsu Hatakeyama1, Satoshi Kano1, Takatsugu Mizumachi1, Tomohiko Kakizaki1, Takayoshi Suzuki1, Satoshi Fukuda1.   

Abstract

Prophylactic neck dissection (PND) for patients with clinically N0 (cN0) tongue carcinoma remains controversial. We assessed the efficacy of PND for patients with cN0 tongue squamous cell carcinoma (SCC) and investigated the prognostic role of tumor thickness as assessed by diagnostic imaging in predicting the risk of nodal micrometastasis or late nodal recurrence. Eighty-eight patients with cN0 tongue carcinomas underwent surgical treatment. Tumor thickness was measured from magnetic resonance (MR) images or computed tomography (CT) scans. The overall survival rates of patients with or without PND were 94 and 81 %, respectively (p = 0.2857). MR images or CT scans were available for 68 patients. A tumor thickness ≥10 mm or ≥5 mm did not increase the probability of nodal metastasis, with late nodal metastasis observed in 15 % of patients with graphically undetected small tumors. PND appears to have the potential to improve overall survival for patients with cN0 tongue SCC. Careful follow-up management or PND is considered to be needed regardless of tumor thickness in the pre-treatment evaluation.

Entities:  

Keywords:  Neck dissection; Nodal metastasis; Tongue cancer; Tumor thickness

Mesh:

Year:  2016        PMID: 27149875     DOI: 10.1007/s00405-016-4077-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  15 in total

1.  T1 and T2 squamous cell carcinoma of the oral tongue: prognostic factors and the role of elective lymph node dissection.

Authors:  S W Beenken; H Krontiras; W A Maddox; G E Peters; S Soong; M M Urist
Journal:  Head Neck       Date:  1999-03       Impact factor: 3.147

2.  Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection.

Authors:  K J Haddadin; D S Soutar; R J Oliver; M H Webster; A G Robertson; D G MacDonald
Journal:  Head Neck       Date:  1999-09       Impact factor: 3.147

3.  Accuracy of MRI in prediction of tumour thickness and nodal stage in oral squamous cell carcinoma.

Authors:  Christine T Lwin; Rebecca Hanlon; Derek Lowe; James S Brown; Julia A Woolgar; Asterios Triantafyllou; Simon N Rogers; Fazilet Bekiroglu; Huw Lewis-Jones; Hulya Wieshmann; Richard J Shaw
Journal:  Oral Oncol       Date:  2011-12-07       Impact factor: 5.337

4.  Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.

Authors:  Anil K D'Cruz; Richa Vaish; Neeti Kapre; Mitali Dandekar; Sudeep Gupta; Rohini Hawaldar; Jai Prakash Agarwal; Gouri Pantvaidya; Devendra Chaukar; Anuja Deshmukh; Shubhada Kane; Supreeta Arya; Sarbani Ghosh-Laskar; Pankaj Chaturvedi; Prathamesh Pai; Sudhir Nair; Deepa Nair; Rajendra Badwe
Journal:  N Engl J Med       Date:  2015-05-31       Impact factor: 91.245

5.  Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

Authors:  Jacques Bernier; Jay S Cooper; T F Pajak; M van Glabbeke; J Bourhis; Arlene Forastiere; Esat Mahmut Ozsahin; John R Jacobs; J Jassem; Kie-Kian Ang; J L Lefèbvre
Journal:  Head Neck       Date:  2005-10       Impact factor: 3.147

6.  Elective versus therapeutic neck dissection in early carcinoma of the oral tongue.

Authors:  A R Fakih; R S Rao; A M Borges; A R Patel
Journal:  Am J Surg       Date:  1989-10       Impact factor: 2.565

7.  Elective neck dissection in early-stage oral squamous cell carcinoma--does it influence recurrence and survival?

Authors:  Ana Capote; Veronica Escorial; Mario F Muñoz-Guerra; Francisco J Rodríguez-Campo; Carlos Gamallo; Luis Naval
Journal:  Head Neck       Date:  2007-01       Impact factor: 3.147

Review 8.  Elective versus therapeutic neck dissection in node-negative oral cancer: Evidence from five randomized controlled trials.

Authors:  Zhen-Hu Ren; Jian-Lin Xu; Bo Li; Teng-Fei Fan; Tong Ji; Chen-Ping Zhang
Journal:  Oral Oncol       Date:  2015-08-28       Impact factor: 5.337

9.  Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma.

Authors:  Anthony Po-Wing Yuen; Chiu Ming Ho; Tam Lin Chow; Lap Chiu Tang; Wing Yung Cheung; Raymond Wai-Man Ng; William Ignace Wei; Chi Kwan Kong; Kwok Shing Book; Wai Cheung Yuen; Alfred King-Yin Lam; Nancy Wah-Fun Yuen; Nigel Jeremy Trendell-Smith; Yue Wai Chan; Birgitta Yee-Hang Wong; George Kam-Hop Li; Ambrose Chung-Wai Ho; Wai Kuen Ho; Sau Yan Wong; Tzy-Jyun Yao
Journal:  Head Neck       Date:  2009-06       Impact factor: 3.147

10.  Recurrent neck disease in oral cancer.

Authors:  Daryl R P Godden; N F F Ribeiro; K Hassanein; S G Langton
Journal:  J Oral Maxillofac Surg       Date:  2002-07       Impact factor: 1.895

View more
  11 in total

1.  Validation of the 8th edition of the AJCC/UICC TNM staging system for tongue squamous cell carcinoma.

Authors:  Satoshi Kano; Tomohiro Sakashita; Nayuta Tsushima; Takatsugu Mizumachi; Akira Nakazono; Takayoshi Suzuki; Shinichiro Yasukawa; Akihiro Homma
Journal:  Int J Clin Oncol       Date:  2018-04-19       Impact factor: 3.402

2.  MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion.

Authors:  Lanying Sun; Jin Liang; Qibao Wang; Zhaoyuan Li; Yi Du; Xin Xu
Journal:  Cell Prolif       Date:  2016-08-30       Impact factor: 6.831

3.  Early tongue carcinomas (clinical stage I and II): echo-guided three-dimensional diode laser mini-invasive surgery with evaluation of histological prognostic parameters. A study of 85 cases with prolonged follow-up.

Authors:  Luisa Limongelli; Saverio Capodiferro; Angela Tempesta; Pasquale Sportelli; Fabio Dell'Olio; Giuseppe Angelelli; Eugenio Maiorano; Gianfranco Favia
Journal:  Lasers Med Sci       Date:  2019-12-13       Impact factor: 3.161

4.  Inhibition of microRNA-17 enhances cisplatin-induced apoptosis of human tongue squamous carcinoma cell.

Authors:  Yang Sun; Wei Nie; Bo Qiu; Xiangjun Guo; Jian Zhang; Jianming Wei
Journal:  J Bioenerg Biomembr       Date:  2021-01-18       Impact factor: 2.945

5.  Circulating hybrid cells predict presence of occult nodal metastases in oral cavity carcinoma.

Authors:  Tara E Henn; Ashley N Anderson; Yvette R Hollett; Thomas L Sutton; Brett S Walker; John R Swain; David A Sauer; Daniel R Clayburgh; Melissa H Wong
Journal:  Head Neck       Date:  2021-04-09       Impact factor: 3.821

6.  MicroRNA‑509 acts as a tumor suppressor in tongue squamous cell carcinoma by targeting epidermal growth factor receptor.

Authors:  Chao Hou; Yan Dong; Fenghe Zhang; Bo Du
Journal:  Mol Med Rep       Date:  2017-09-20       Impact factor: 2.952

7.  Surgical treatment of early tongue squamous cell carcinoma and patient survival.

Authors:  Lansheng Zhu; Yanling Wang; Rui Li; Aiqun Liu; Xiaoping Zhang; Chunran Zuo; Xiaoting Xu
Journal:  Oncol Lett       Date:  2019-04-18       Impact factor: 2.967

8.  Cancer associated fibroblasts are distinguishable from peri-tumor fibroblasts by biological characteristics in TSCC.

Authors:  Pengfei Ba; Xiaojuan Zhang; Miao Yu; Linxia Li; Xiaoyu Duan; Mingying Wang; Shuyan Lv; Guo Fu; Pishan Yang; Chengzhe Yang; Qinfeng Sun
Journal:  Oncol Lett       Date:  2019-07-04       Impact factor: 2.967

9.  Survival Outcomes in Oral Tongue Cancer: A Mono-Institutional Experience Focusing on Age.

Authors:  Mohssen Ansarin; Rita De Berardinis; Federica Corso; Gioacchino Giugliano; Roberto Bruschini; Luigi De Benedetto; Stefano Zorzi; Fausto Maffini; Fabio Sovardi; Carolina Pigni; Donatella Scaglione; Daniela Alterio; Maria Cossu Rocca; Susanna Chiocca; Sara Gandini; Marta Tagliabue
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

10.  CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma.

Authors:  Yue Chen; Tian Tian; Min-Jie Mao; Wei-Ye Deng; Hao Li
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.